Fortitude Family Office’s Humacyte HUMA Stock Holding History

Fortitude Family Office’s Portfolio HUMA Stock Details HUMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$476	Buy	+610	New	+$565	﹤0.01%	1992

Other funds holding HUMA

United Asset Strategies Garden City, New York $1.41B AUM 27.73% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Clarus Wealth Advisors Peoria, Arizona $260M AUM 27.97% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

V.M. Manning & Co Greenville, South Carolina $117M AUM

Trust Company of Kansas Wichita, Kansas $195M AUM 27.88% 1-Year Est. Return

Hamilton Lane Advisors Conshohocken, Pennsylvania $149M AUM 14.17% 1-Year Est. Return

Columbia Advisory Partners Spokane, Washington $181M AUM 25.77% 1-Year Est. Return

Fortitude Family Office's HUMA Position: Q2 2026 in Review

Fortitude Family Office opened a new position in Humacyte (HUMA) in Q2 2026: 610 shares worth $476. The stake represents ﹤0.01% of the portfolio and ranks #1992 among its holdings.

34 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

Fortitude Family Office held 610 shares of Humacyte worth $476 as of Q2 2026.
Humacyte was a new Fortitude Family Office position in Q2 2026.
Humacyte made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1992 holding.
34 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.